Abbott Entering Embolic Protection, Carotid Stent Markets Via MedNova
This article was originally published in The Gray Sheet
Executive Summary
Abbott Labs is anticipating FDA approval of MedNova's CardioShield embolic filter device for saphenous vein graft applications in 2003, following a Feb. 2 announcement of an exclusive worldwide distribution agreement between the companies.
You may also be interested in...
Transcathether Cardiovascular Therapeutics Meeting In Brief
Carotid stenting: MedNova EmboShield wire-filter distal protection system used with Xact self-expanding carotid stents is associated with a 7.2% 30-day major adverse event rate, according to preliminary results from the SECuRITY registry. Presented at the recent Transcatheter Cardiovascular Therapeutics meeting in Washington, D.C. by investigator Patrick Whitlow, MD, Cleveland Clinic, the data included evaluation of the devices in 305 patients with high surgical risks. The trial is being supported by Abbott Vascular, which has exclusive distribution rights (1"The Gray Sheet" Feb. 5, 2001, p. 23)...
Transcathether Cardiovascular Therapeutics Meeting In Brief
Carotid stenting: MedNova EmboShield wire-filter distal protection system used with Xact self-expanding carotid stents is associated with a 7.2% 30-day major adverse event rate, according to preliminary results from the SECuRITY registry. Presented at the recent Transcatheter Cardiovascular Therapeutics meeting in Washington, D.C. by investigator Patrick Whitlow, MD, Cleveland Clinic, the data included evaluation of the devices in 305 patients with high surgical risks. The trial is being supported by Abbott Vascular, which has exclusive distribution rights (1"The Gray Sheet" Feb. 5, 2001, p. 23)...
Abbott Expands Commitment To Vascular Device Biz Through Biocompatibles
Abbott's acquisition of Biocompatibles' stent business, unveiled March 18, reflects an expanded commitment by Abbott to its vascular medicine franchise - particularly focusing on high growth market segments like stents, vessel closure and embolic protection